Related Experiment Videos
A year's experience of the Roche Advantage II glucose test strip
1Department of Clinical Biochemistry, The Princess Royal Hospital, Lewes Road, Haywards Heath, West Sussex RH17 4EX, UK. SJFrost@bigfoot.com
Summary
Statistical analysis of a quality assurance program shows improved performance for the Advantage II glucose test strip. This new near-patient blood glucose monitoring tool has been used in our hospital for over a year.
Area of Science:
- Clinical Chemistry
- Medical Diagnostics
- Point-of-Care Testing
Background:
- Near-patient blood glucose measurement is crucial for effective diabetes management.
- Quality assurance schemes are vital for ensuring the accuracy of diagnostic tests.
- Evaluating new diagnostic tools is essential for improving healthcare outcomes.
Purpose of the Study:
- To statistically analyse the findings of a ward-based quality assurance scheme.
- To assess the analytical performance of the Advantage II glucose test strip.
- To provide evidence supporting the efficacy of new near-patient testing methods.
Main Methods:
- Statistical analysis of data from a quality assurance scheme.
- Evaluation of near-patient blood glucose measurements.
- Longitudinal assessment of a new glucose meter test strip (Advantage II) over one year.
Main Results:
- The quality assurance scheme provided statistically significant data.
- Evidence supports improved analytical performance of the Advantage II test strip.
- The new test strip has demonstrated reliable performance in a clinical setting.
Conclusions:
- The Advantage II test strip demonstrates enhanced analytical performance.
- Ward-based quality assurance is effective in validating new diagnostic technologies.
- The findings support the continued use of the Advantage II test strip for near-patient blood glucose monitoring.